Infrastructure of the Future

Our scale enables us to spot trends early and invest in advancements across artificial intelligence, power, the digital economy, and life sciences.

  • Greg Blank on Infrastructure Investing’s Trillion Dollar Opportunities

    Chief Executive Officer of Blackstone Infrastructure Strategies Greg Blank discusses the three key focus areas for infrastructure investing right now.

    Interviewing AI on Blackstone’s Investments in Data Centers

    Head of Digital Infrastructure for Blackstone Real Estate Mike Forman and Chief Executive Officer of Blackstone Infrastructure Strategies Greg Blank discuss our global data center strategy with a special guest — AI.

    Investing in the Picks and Shovels of AI

    The rise of AI is unlocking historic opportunities in the infrastructure and technologies that enable it. We’re using our scale and expertise to invest in the “picks and shovels” shaping its future.

  • The Convergence of Data Centers and Power: A Generational Investment Opportunity

    Global Head of Infrastructure Sean Klimczak discusses an exciting and pivotal investment theme — the intersection of digital infrastructure and the need for power — for building the infrastructure of future.

    Blackstone Infrastructure Enters Agreement to Acquire TXNM Energy

    Blackstone Infrastructure announces an agreement to acquire TXNM Energy which through its subsidiaries PNM and TNMP is focused on meeting the critical electricity infrastructure needs of its customers.

    Blackstone Energy Transition Partners

    Explore how Blackstone enables leading energy companies to build enterprises at scale that can deliver clean, reliable, and affordable energy to help meet global needs.

  • Building the Future: Megatrends and Investment Themes

    Learn about Blackstone’s investment strategy and how we aim to be at the forefront of the megatrends shaping the future.

    Blackstone Launches New Pan-European Logistics Platform

    Blackstone announces the launch on Proxity, a new pan-European logistics operator and developer.

    What Does Pickleball Have To Do With Warehouse Demand?

    Watch how Blackstone makes connections that help build wealth for investors.

  • Nick Galakatos on
    “A Differentiated Approach to Life Sciences Investing”

    Dr. Nick Galakatos, Global Head of Blackstone Life Sciences, discussed his differentiated approach to life sciences investing, strategy for mitigating risk, and outlook for the sector.

    Blackstone Life Sciences Invests in GRIN Therapeutics

    GRIN Therapeutics announces the closing of its $140 million Series D financing with investment by Angelini Pharma and Blackstone Life Sciences.

    Blackstone Life Sciences

    Explore how Blackstone aims to bring vital medicines and technologies to market by designing, funding, and executing clinical trials for products generally in late-stage development.

Stay up-to-date

Sign up for our latest insights and firm announcements.

Please fill out this field.
Please fill out this field.
Please fill out this field.
Please fill out this field.
Please fill out this field.

You have successfully submitted your information

International Data Corporation (IDC), as of May 2024. 2024-2028 represent year-end estimates.
EIA, as of November 2024 and NREL as of August 2022. Reflects total net electricity generation. Figures for 2024 and beyond reflect estimates.
GridStrategies, 2024.
Lazard LCOE Report as of June 2025, and LevelTen Energy Report as of January 2025. Based on the fact that ~95% of the interconnection queue is renewables (wind and solar) and amount to $1.5B/GW to build in North America. Assumes 2600 gigawatts in the current transmission queue, per Lawrence Berkeley National Laboratory, as of January 2025.
US Census Bureau, as of June 30, 2025. Figures reflect trailing twelve-month values.
Deloitte Analysis, 2022.
The annual funding gap is Blackstone Life Sciences’ estimate of the gap between the annual spread between the demand for medicine and device development capital and the supply of development capital from Biopharma and MedTech companies through R&D budgets. Data sources are Evaluate Pharma and Morgan Stanley, Market Update Presentation to Blackstone Life Sciences. January 2024.